Corrigendum to “ABCC8 genetic variants and risk of diabetes mellitus” [Gene 545 (2014) 198–204] (ABCC8 genetic variants and risk of diabetes mellitus (2014) 545(2) (198–204), (S0378111914004715), (10.1016/j.gene.2014.04.040));ABCC8 genetic variants and risk of diabetes mellitus

Gene

Volumn 545, Issue 2, 2014, Pages 198-204

  Haghverdizadeh, Polin ^a   Sadat Haerian, Monir ^b   Haghverdizadeh, Pantea ^c   Sadat Haerian, Batoul ^d  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

ABCC8; Diabetes mellitus; Polymorphism

Indexed keywords

SULFONYLUREA RECEPTOR 1;

ABCC8 GENE; ALLELE; AMINO ACID SUBSTITUTION; DIABETES MELLITUS; GENE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INSULIN RELEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ABCC8; DIABETES MELLITUS; POLYMORPHISM;

ANIMALS; DIABETES MELLITUS; EPISTASIS, GENETIC; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HAPLOTYPES; HUMANS; INSULIN; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; SULFONYLUREA RECEPTORS;

EID: 84901611091     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2020.144686     Document Type: Erratum

References (57)

1. Ahlqvist E., Ahluwalia T.S., Groop L. Genetics of type 2 diabetes. Clinical Chemistry 2011, 57(2):241-254.
2. Bailey-Wilson J.E., Wilson A.F. Linkage analysis in the next-generation sequencing era. Human Heredity 2011, 72:228-236.
3. Barroso I., Luan J.A., Middelberg R.P., Harding A.H., Franks P.W., Jakes R.W., Wareham N.J. Candidate gene association study in type 2 diabetes indicates a role for genes involved in β-cell function as well as insulin action. PLoS Biology 2003, 1(1):e20.
4. Biemans-Oldehinkel E., Doeven M.K., Poolman B. ABC transporter architecture and regulatory roles of accessory domains. FEBS Letters 2006, 580(4):1023-1035.
5. Chistiakov D.A., Potapov V.A., Khodirev D.C., Shamkhalova M.S., Shestakova M.V., Nosikov V.V. Genetic variations in the pancreatic ATP-sensitive potassium channel, β-cell dysfunction, and susceptibility to type 2 diabetes. Acta Diabetologica 2009, 46(1):43-49.
6. De Knijff P., Dekker J.M., Stolk R.P., Nijpels G., van der Does F.E.E., Ruige J.B., Maassen J.A. Variants in the sulphonylurea receptor gene: association of the exon 16-3t variant with type II diabetes mellitus in Dutch Caucasians. Diabetologia 1999, 42(5):617-620.
7. Dean M., Hamon Y., Chimini G. The Human ATP-binding Cassette (ABC) 2001.
8. DIAbetes Genetics replication and meta-analysis DIAGRAM.Consortium Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nature Genetics 2014, 46(3):234-244.
9. Dorman J.S., Bunker C.H. HLA-DQ locus of the human leukocyte antigen complex and type 1 diabetes mellitus: a HuGE review. Epidemiologic Reviews 2000, 22:218-227.
10. Dworacka M., Winiarska H., Jagodziński P.P. Impact of the sulfonylurea receptor 1 (SUR1) exon 16-3c/t polymorphism on acute hyperglycaemia in type 2 diabetic patients. Diabetes Research and Clinical Practice 2007, 77(2):258-262.
11. Feng Y., Mao G., Ren X., Xing H., Tang G., Li Q., Xu X. Ser1369Ala variant in sulfonylurea receptor gene ABCC8 is associated with antidiabetic efficacy of gliclazide in Chinese type 2 diabetic patients. Diabetes Care 2008, 31(10):1939-1944.
12. Flores J.C., Hirschhorn J., Altshuler D. The inherited basis of diabetes mellitus: implications for the genetic analysis of complex traits. Annual Review of Genomics and Human Genetics 2003, 4:257-291.
13. Florez J.C., Burtt N., De Bakker P.I., Almgren P., Tuomi T., Holmkvist J., Altshuler D. Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region. Diabetes 2004, 53(5):1360-1368.
14. Florez J.C., Jablonski K.A., Kahn S.E., Franks P.W., Dabelea D., Hamman R.F., Altshuler D. Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program. Diabetes 2007, 56(2):531-536.
15. Gloyn A.L., Hashim Y., Ashcroft S.J.H., Ashfield R., Wiltshire S., Turner R.C. Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with type 2 diabetes mellitus (UKPDS 53). Diabetic Medicine 2001, 18(3):206-212.
16. Goksel D.L., Fischbach K., Duggirala R., Mitchell B.D., Aguilar-Bryan L., Blangero J., O'Connell P. Variant in sulfonylurea receptor-1 gene is associated with high insulin concentrations in non-diabetic Mexican Americans: SUR-1 gene variant and hyperinsulinemia. Human Genetics 1998, 103(3):280-285.
17. Gonen M.S., Arikoglu H., Erkoc Kaya D., Ozdemir H., Ipekci S.H., Arslan A., Gogebakan B. Effects of single nucleotide polymorphisms in K(ATP) channel genes on type 2 diabetes in a Turkish population. Archives of Medical Research 2012, 43(4):317-323.
18. Hansen T., Echwald S.M., Hansen L., Møller A.M., Almind K., Clausen J.O., Pedersen O. Decreased tolbutamide-stimulated insulin secretion in healthy subjects with sequence variants in the high-affinity sulfonylurea receptor gene. Diabetes 1998, 47(4):598-605.
19. He Y.Y., Zhang R., Shao X.Y., Hu C., Wang C.R., Lu J.X., Jia W.P. Association of KCNJ11 and ABCC8 genetic polymorphisms with response to repaglinide in Chinese diabetic patients. Acta Pharmacologica Sinica 2008, 29(8):983-989.
20. Hivert M.F., Vassy J.L., Meigs J.B. Susceptibility to type 2 diabetes mellitus - from genes to prevention. Nature Reviews Endocrinology 2014, 10(4):198-205.
21. Ishiyama-Shigemoto S., Yamada K., Yuan X., Koyama W., Nonaka K. Clinical characterization of polymorphisms in the sulphonylurea receptor 1 gene in Japanese subjects with type 2 diabetes mellitus. Diabetic Medicine 1998, 15(10):826-829.
22. Ji L., Han X., Wang H. Sulfonylurea receptor gene polymorphism is associated with non-insulin dependent diabetes mellitus in Chinese population. Zhonghua Yi Xue Za Zhi 1998, 78(10):774-775.
23. Kapoor R. Defining Genotype-Phenotype Correlations in Children With Congenital Hyperinsulinism 2010, University College London, (Doctoral dissertation).
24. Kilpeläinen T.O., Lakka T.A., Laaksonen D.E., Laukkanen O., Lindström J., Eriksson J.G., Laakso M. Physical activity modifies the effect of SNPs in the SLC2A2 (GLUT2) and ABCC8 (SUR1) genes on the risk of developing type 2 diabetes. Physiological Genomics 2007, 31(2):264-272.
25. Kilpeläinen T.O., Lakka T.A., Laaksonen D.E., Mager U., Salopuro T., Kubaszek A., Todorova B., Laukkanen O., Lindström J., Eriksson J.G., Hämäläinen H., Aunola S., Ilanne-Parikka P., Keinänen-Kiukaanniemi S., Tuomilehto J., Laakso M., Uusitupa M. Finnish Diabetes Prevention Study Group. Interaction of single nucleotide polymorphisms in ADRB2, ADRB3, TNF, IL6,IGF1R, LIPC, LEPR, and GHRL with physical activity on the risk of type 2 diabetes mellitus and changes incharacteristics of the metabolic syndrome: The Finnish Diabetes Prevention Study. Metabolism 2008, 57(3):428-436.
26. Lang V., Youssef N., Light P.E. The molecular genetics of sulfonylurea receptors in the pathogenesis and treatment of insulin secretory disorders and type 2 diabetes. Current Diabetes Reports 2011, 11(6):543-551.
27. Laukkanen O., Pihlajamäki J., Lindström J., Eriksson J., Valle T.T., Hämäläinen H., Laakso M. Polymorphisms of the SUR1 (ABCC8) and Kir6.2 (KCNJ11) genes predict the conversion from impaired glucose tolerance to type 2 diabetes. The Finnish Diabetes Prevention Study. Journal of Clinical Endocrinology & Metabolism 2004, 89(12):6286-6290.
28. Maa Bared S. Identification and Characterization of ABCA1-interactive Proteins and Their Relevance to Atherosclerosis 2005, (Doctoral dissertation).
29. Matharoo K., Arora P., Bhanwer A.J.S. Association of adiponectin (AdipoQ) and sulphonylurea receptor (ABCC8) gene polymorphisms with type 2 diabetes in North Indian population of Punjab. Gene 2013, 527(1):228-234.
30. Meirhaeghe A., Helbecque N., Cottel D., Arveiler D., Ruidavets J.B., Haas B., Amouyel P. Impact of sulfonylurea receptor 1 genetic variability on non-insulin-dependent diabetes mellitus prevalence and treatment: a population study. American Journal of Medical Genetics 2001, 101(1):4-8.
31. Mitchell A.A., Chakravarti A., Cutler D.J. On the probability that a novel variant is a disease-causing mutation. Genome Research 2005, 15:960-966.
32. Moleda P1., Bińczak-Kuleta A., Homa K., Safranow K., Celewicz Z., Syrenicz A., Stefański A., Fronczyk A., Majkowska L. The common C49620T polymorphism in the sulfonylurea receptor gene SUR1 (ABCC8) in patients with gestational diabetes and subsequent glucose metabolism abnormalities. Exp Diabetes Res. 2012, 2012:712617.
33. Nikolac N., Simundic A.M., Katalinic D., Topic E., Cipak A., Zjacic Rotkvic V. Metabolic control in type 2 diabetes is associated with sulfonylurea receptor-1 (SUR-1) but not with KCNJ11 polymorphisms. Archives of Medical Research 2009, 40(5):387-392.
34. Nikolac N., Simundic A.M., Saracevic A., Katalinic D. ABCC8 polymorphisms are associated with triglyceride concentration in type 2 diabetics on sulfonylurea therapy. Genetic Testing and Molecular Biomarkers 2012, 16(8):924-930.
35. Niu X.M., Yang H., Zhang H.Y., Li N.J., Qi X.M., Chang Y., Zhang Y. Study on association between gestational diabetes mellitus and sulfonylurea receptor-1 gene polymorphism. Zhonghua Fu Chan Ke Za Zhi 2005, 40(3):159-163.
36. Odgerel Z., Lee H.S., Erdenebileg N., Gandbold S., Luvsanjamba M., Sambuughin N., Goldfarb L.G. Genetic variants in potassium channels are associated with type 2 diabetes in a Mongolian population. Journal of Diabetes 2012, 4(3):238-242.
37. Pohl A., Devaux P.F., Herrmann A. Function of prokaryotic and eukaryotic ABC proteins in lipid transport. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2005, 1733(1):29-52.
38. Prudente S., Dallapiccola B., Pellegrini F., Doria A., Trischitta V. Genetic prediction of common diseases. Still no help for the clinical diabetologist. Nutrition, Metabolism, and Cardiovascular Diseases 2012, 22(11):929-936.
39. Quan W., Jo E.K., Lee M.S. Role of pancreatic β-cell death and inflammation in diabetes. Diabetes Obes Metab. 2013, 15(Suppl 3):141-151.
40. Reis A.F., Ye W.Z., Dubois-Laforgue D., Bellanné-Chantelot C., Timsit J., Velho G. Association of a variant in exon 31 of the sulfonylurea receptor 1 (SUR1) gene with type 2 diabetes mellitus in French Caucasians. Human Genetics 2000, 107(2):138-144.
41. Reis A.F., Hani E.H., Beressi N., Robert J.J., Bresson J.L., Froguel P., Velho G. Allelic variation in exon 18 of the sulfonylurea receptor 1 (SUR1) gene, insulin secretion and insulin sensitivity in nondiabetic relatives of type 2 diabetic subjects. Diabetes and Metabolism 2002, 28(3):209-215.
42. Rissanen Johanna, Markkanen A., Kärkkäinen Päivi, Pihlajamäki Jussi, Kekäläinen Päivi, Mykkänen Leena, Laakso Markku Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin. Diabetes Care 2000, 23(1):70-73.
43. Ryan E.A., Enns L. Role of gestational hormones in the induction of insulin resistance. Journal of Clinical Endocrinology & Metabolism 1988, 67:341-347.
44. Sakamoto Y., Inoue H., Keshavarz P., Miyawaki K., Yamaguchi Y., Moritani M., Itakura M. SNPs in the KCNJ11-ABCC8 gene locus are associated with type 2 diabetes and blood pressure levels in the Japanese population. Journal of Human Genetics 2007, 52(10):781-793.
45. Sato R., Watanabe H., Genma R., Takeuchi M., Maekawa M., Nakamura H. ABCC8 polymorphism (Ser1369Ala): influence on severe hypoglycemia due to sulfonylureas. Pharmacogenomics 2010, 11(12):1743-1750.
46. Schwenk R.W., Vogel H., Schürmann A. Genetic and epigenetic control of metabolic health. Molecular Metabolism 2013, 2(4):337-347.
47. Stefanski A., Majkowska L., Ciechanowicz A., Franków M., Safranow K., Parczewski M., Pilarska K. The common C49620T polymorphism in the sulfonylurea receptor gene (ABCC8), pancreatic beta cell function and long-term diabetic complications in obese patients with long-lasting type 2 diabetes mellitus. Experimental and Clinical Endocrinology and Diabetes 2007, 115(05):317-321.
48. + channel activity and β-cell glucose sensing is associated with type 2 diabetes in adults. Diabetes 2008, 57(6):1595-1604.
49. Waldron-Lynch Frank, Herold Kevan C. Immunomodulatory therapy to preserve pancreatic β-cell function in type 1 diabetes. Nature Reviews. Drug Discovery 2011, 10:439-452.
50. Wang J.S., Zhou L., Cheng J.L., Shen M.Y. Study on the relationship between sulfonylurea receptor 1 gene polymorphism and type 2 diabetes mellitus. Yi Chuan = Hereditas/Zhongguo yi chuan xue hui bian ji 2004, 26(1):8-12.
51. Wang F., Han X.Y., Ren Q., Zhang X.Y., Han L.C., Luo Y.Y., Ji L.N. Effect of genetic variants in KCNJ11, ABCC8, PPARG and HNF4A loci on the susceptibility of type 2 diabetes in Chinese Han population. Chinese Medical Journal (English Edition) 2009, 122(20):2477.
52. Weisnagel S.J., Rankinen T., Nadeau A., Rao D.C., Chagnon Y.C., Pérusse L., Bouchard C. Decreased fasting and oral glucose stimulated C-peptide in nondiabetic subjects with sequence variants in the sulfonylurea receptor 1 gene. Diabetes 2001, 50(3):697-702.
53. Wilkin T.J. The accelerator hypothesis: a review of the evidence for insulin resistance as the basis for type I as well as type II diabetes. International Journal of Obesity 2009, 33:716-726.
54. Yokoi N., Kanamori M., Horikawa Y., Takeda J., Sanke T., Furuta H., Seino S. Association studies of variants in the genes involved in pancreatic β-cell function in type 2 diabetes in Japanese subjects. Diabetes 2006, 55(8):2379-2386.
55. Zhang H., Liu X., Kuang H., Yi R., Xing H. Association of sulfonylurea receptor 1 genotype with therapeutic response to gliclazide in type 2 diabetes. Diabetes Research and Clinical Practice 2007, 77(1):58-61.
56. Zimmet P.Z., Magliano D.J., Herman W.H., Shaw J.E. Diabetes: a 21st century challenge. The Lancet. Diabetes & Endocrinology 2014, 2(1):56-64.
57. Zychma M.J., Gumprecht J., Strojek K., Grzeszczak W., Moczulski D., Trautsolt W., Karasek D. Sulfonylurea receptor gene 16-3 polymorphism-association with sulfonylurea or insulin treatment in type 2 diabetic subjects. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research 2002, 8(7):CR512-CR515.